In Re: Bextra and Celebrex Product Liability Litigation, MDL No. 1699
Appointed to the Plaintiff’s Steering Committee, Tom Cartmell also served as co-lead trial counsel for the lead, bellwether case that settled on the eve of trial, paving the way for settlement for all cases in the MDL for more than $745 million.
About The Case
Tom Cartmell was appointed by the Honorable Charles R. Breyer of the Northern District of California as a member of the Plaintiff’s Steering Committee on this case. He also served as co-lead trial counsel in this product liability multi-district litigation arising out of the use of the medications Bextra and Celebrex. The lead case settled on the eve of trial and ultimately all cases in the MDL settled for more than $745 million.